PMID: 11607043Oct 19, 2001Paper

Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist

CNS Drug Reviews
R Nadal

Abstract

Remoxipride is a substituted benzamide that acts as a weak but very selective antagonist of dopamine D2 receptors. It was introduced by Astra (Roxiam) at the end of the eighties and was prescribed as an atypical antipsychotic. This article reviews its putative selective effects on mesolimbic versus nigrostriatal dopaminergic systems. In animals, remoxipride has minimal cataleptic effects at doses that block dopamine agonist-induced hyperactivity. These findings are predictive of antipsychotic activity with a low likelihood of extrapyramidal symptoms. Remoxipride also appears to be effective in more recent animal models of schizophrenia, such as latent inhibition or prepulse inhibition. In clinical studies, remoxipride shows a relatively low incidence of extrapyramidal side effects and its effects on prolactin release are short-lasting and generally mild. The clinical efficacy of remoxipride is similar to that of haloperidol or chlorpromazine. Although its clinical use was severely restricted in 1993, due to reports of aplastic anemia in some patients receiving remoxipride, this drug has been found to exhibit relatively high selectivity for dopamine D2 receptors making remoxipride an interesting tool for neurochemical and behavi...Continue Reading

References

Feb 1, 1992·Neuropharmacology·G A Gudelsky, J F Nash
Jun 5, 1992·European Journal of Pharmacology·H Ericson, S B Ross
Apr 1, 1991·Acta Physiologica Scandinavica·K Fuxe, S O Ogren
Nov 1, 1991·The American Journal of Psychiatry·K L DavisM Davidson
Sep 1, 1991·British Journal of Clinical Pharmacology·G Movin-Osswald, M Hammarlund-Udenaes
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·J AndersenE M Møller-Nielsen
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·R DeoA Chanas
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·L H LindströmL Naimell
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·J MendlewiczE Suy
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·A L Phanjoo, C Link
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·P Seeman
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·S O OgrenK Angeby-Möller
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·C KöhlerK Gustafsson
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·C von BahrM Widman
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·W YisakS Ogenstad
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·L Farde, C von Bahr
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·Y D LapierreR Manchanda
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·M PatrisM Goudemand
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·U G AhlforsJ Outakoski
Jan 1, 1989·European Journal of Clinical Pharmacology·E WiderlövM I Nilsson
Oct 18, 1988·European Journal of Pharmacology·B L LargentS H Snyder
Jul 1, 1988·Acta Psychiatrica Scandinavica·R G McCreadieB Huitfeldt
Oct 14, 1983·European Journal of Pharmacology·P Seeman, C Ulpian
Aug 1, 1995·Trends in Pharmacological Sciences·P Sokoloff, J C Schwartz
Feb 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·R W Kerwin
May 1, 1995·British Journal of Clinical Pharmacology·G Movin-OsswaldK Walton-Bowen
Dec 15, 1994·European Journal of Pharmacology·A Westlind-DanielssonI Andersson
Nov 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·J GeorgievaO Magnusson
Nov 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S O Ogren, M Goldstein

❮ Previous
Next ❯

Citations

Jun 26, 2004·The European Journal of Neuroscience·Akeel A ShahDallas Treit
Jan 26, 2011·Journal of Cognitive Neuroscience·Martin WienerH Branch Coslett
Apr 6, 2016·The Cochrane Database of Systematic Reviews·Kumar B SahaRashid U Zaman
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·John Cl Erve
Jul 30, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer T CoullWarren H Meck
Aug 20, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Louiza Belkacemi, Nissar A Darmani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here